Nermine S. Ghoniem

Nermine S. Ghoniem

Auto-generated profile, based on publicly available information

Nermine S. Ghoniem

Pharmaceutical Analytical Chemistry Department, Faculty of Pharmacy, Cairo University

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 January 2024 in BMC Chemistry
Verified
Journal Article
Open access
PDF file
HNHend M. Nagieb
Hend M. Nagieb
NANada S. Abdelwahab
Nada S. Abdelwahab
MAMaha M. Abdelrahman
Maha M. Abdelrahman
HZHala E. Zaazaa
Hala E. Zaazaa
NGNermine S. Ghoniem
Nermine S. Ghoniem
Preserving the environment, reducing the amount of waste resulting from chemical trials, and reducing the amount of energy consumed have currently become a pivotal global trend. An analytical quality by design (AQbD) based eco-friendly TLC-densitometric method was implemented for quantifying two antihypertensive agents, captopril (CPL) and hydrochlorothiazide (HCZ), along with their impurities; captopril disulphide (CDS), chlorothiazide (CTZ) and salamide (SMD). The analytical target profile (ATP) was first identified, followed by selecting the critical analytical attributes (CAAs), such as retardation factors and resolution between the separated peaks. Critical method parameters (CMPs) that may have a crucial influence on CAAs were identified and emanated through the quality risk assessment phase. A literature survey-based preliminary studies were performed, followed by optimization of the selected CMPs through a custom experimental design to attain the highest resolution with optimum retardation factors. Moreover, method robustness was also tested by testing the design space. Complete separation of the drugs and their impurities was achieved using ethyl acetate: glacial acetic acid (6: 0.6, v/v) as a developing system applied to a 12 cm length TLC plate at room temperature with UV scanning at 215 nm. Calibration graphs were found to be linear in the ranges of (0.70–6.00), (0.10–2.00), (0.20–1.00), (0.07–1.50) and (0.05–1.00) µg/band corresponding to CPL, HCZ, CDS, CTZ, and SMD, respectively. Four different green metric tools were used to evaluate the greenness profile of the proposed method, and results showed that it is greener than the reported HPLC method. Method whiteness assessment was also conducted. Moreover, the method performance was evaluated following the ICH guidelines, and the outcomes fell within the acceptable limits. The developed method could be approved for routine assay of the cited components in their pharmaceutical formulations and bulk powder without interference from the reported impurities. The issue of concern is saving money, especially in developing countries.

7 November 2023 in Scientific Reports
Verified
Journal Article
Open access
PDF file
HNHend M. Nagieb
Hend M. Nagieb
NANada S. Abdelwahab
Nada S. Abdelwahab
MAMaha M. Abdelrahman
Maha M. Abdelrahman
HZHala E. Zaazaa
Hala E. Zaazaa
NGNermine S. Ghoniem
Nermine S. Ghoniem
Hypertension is described by the world health organization (WHO) as a serious medical problem that significantly affects the heart, brain and kidneys. It is a major cause of premature death worldwide. The present study aims to quantify the combination of captopril (CPL), hydrochlorothiazide (HCZ) and their harmful impurities; captopril disulphide (CDS), chlorothiaizde (CTZ) and salamide (SMD). In-silico study was conducted for estimation of pharmacokinetic parameters (ADMET) as well as toxicity profile of the proposed impurities. The results showed that the three impurities under investigation had poor permeability to CNS and cannot pass the blood–brain barrier (BBB), reducing the likelihood of causing side effects in the brain. On the other hand, all studied impurities were found to be hepatotoxic. In consequence, a highly sensitive and green ultra-performance liquid chromatography- tandem mass spectrometric (UPLC/MS/MS) method was developed and validated for separation of the cited drugs in the presence of their harmful impurities; methanol and 0.1% formic acid (90:10, v/v) mixture was used as a mobile phase, eluted at a constant flow rate of 0.7 mL/min at room temperature. Detection was adopted using a tandem mass spectrometer in a positive mode only for CPL and negative mode for HCZ, CDS, CTZ and SMD. Separation was performed within 1 min. Calibration graphs were found to be linear in the ranges of (50.0–500.0 ng mL−1), (20.0–500.0 ng mL−1), (10.0–250.0 ng mL−1), (5.0–250.0 ng mL−1) and (20.0–400.0 ng mL−1) corresponding to CPL, HCZ, CDS, CTZ and SMD, respectively. Additionally, comparative study of greenness profile was established for the proposed and reported methods using five green metric tools. The proposed method was found to be greener than the reported HPLC method. The developed (UPLC/MS/MS) method was validated according to (ICH) guidelines and it was found to has greater sensitivity, shorter analysis time and lower environmental impact compared to the reported methods.

1 September 2022 in Journal of the Electrochemical Society
Verified
Journal Article
Closed access
MAMadonna Y. Atta
Madonna Y. Atta
MHMaha A. Hegazy
Maha A. Hegazy
AMAmr M. Mahmoud
Amr M. Mahmoud
NGNermine S. Ghoniem
Nermine S. Ghoniem
Sensitive, precise, and fast differential pulse voltammetric (DPV) method has been developed for determination of meropenem (MER) in pure form, pharmaceutical dosage form, and human plasma. The fabricated sensors are based on basal-plane pyrolytic graphite electrode (BPPGE) substrates that was modified by coating the surface with carbon nanotubes. The modified electrode showed detectable enhancement of the anodic peak current of meropenem from 25.8 to 35.7 μA. Effect of both pH and scan rate on peak current and potential were studied, optimum conditions were found to be at pH = 3.0 and scan rate of 100 mV.s−1. A linear response was obtained over the concentration range of 3.0 × 10−7 to 7.0 × 10−5 M MER in aqueous buffer solution. The suggested sensor is highly sensitive, has short response time, capable of MER detection as low concentration as 1.5 × 10−6 M in human plasma. The proposed sensors shows a great potential towards future fabrication of a point-of-care device to monitor MER level in patients’ plasma to ensure drug safety and efficacy for patients in intensive care unit.

31 October 2024 in Scientific Reports
Verified
Journal Article
Open access
PDF file
PMPassant M. Medhat
Passant M. Medhat
MFManal Mohamed Fouad
Manal Mohamed Fouad
HMHany H. Monir
Hany H. Monir
NGNermine S. Ghoniem
Nermine S. Ghoniem
COVID-19 has been a growing global concern in the past four years. Several syndromes associated with this multi-organ viral infection have been observed since the outbreak. According to estimates, 10–15% of people with SARS-CoV- infection may have post-COVID-19 syndrome. Even months after infection, common residual signs and symptoms include myalgia, exhaustion, shortness of breath, rapid heartbeat, stroke, and memory and cognitive impairment which can negatively affect survivors’ quality of life and may consequently lead to their death. Therefore, it is necessary to think about potential therapy options for dealing with both short and long-term impacts. Paracetamol (a common analgesic and antipyretic) and Dexketoprofen Trometamol (a non-steroidal anti-inflammatory drug) are used together to relieve post-COVID symptoms like myalgia (muscle pain) and headache. Additionally, to prevent thrombotic events, Rivaroxaban is recommended for 35 days following discharge. Thus an eco-friendly HPLC-DAD technique was developed for simultaneous quantification of Paracetamol, Dexketoprofen Trometamol, and Rivaroxaban which are co-administered for treatment of post-COVID-19 syndrome. The suggested method was found to be linear in the concentration ranges of 3.00–45.00 µg/mL, 0.5–50.00 µg/mL, and 0.15–20.00 µg/mL, and a limit of detection down to 0.531 µg/mL, 0.095 µg/mL and 0.047 µg/mL for Paracetamol, Dexketoprofen Trometamol and Rivaroxaban, respectively. This method was effectively used to quantify the studied drugs in their bulk powder and spiked human plasma with high percentage recoveries (96.55–99.46%). The suggested approach was validated per International Conference on Harmonization (ICH) requirements and found to be within the acceptable ranges. The method was developed using Green Analytical Chemistry (GAC) principles, with the solvents used and run time having a significant effect on the method’s greenness. “Non-toxic” ethanol served as the organic modifier in the mobile phase, moreover, the total run time was 12 min making it suitable for the routine analysis of the mentioned drugs in plasma samples. To get a full image of the method’s greenness profile; two most recent greenness assessment tools, the Green Analytical Procedure Index (GAPI), and the Analytical GREEnness metric (AGREE), were employed, with White Analytical Chemistry (WAC) principles proving its environmental safety.

5 August 2024 in Microchemical Journal
Verified
Journal Article
Closed access
PMPassant M. Medhat
Passant M. Medhat
MFManal Mohamed Fouad
Manal Mohamed Fouad
AMAmr M. Mahmoud
Amr M. Mahmoud
NGNermine S. Ghoniem
Nermine S. Ghoniem
HBHany Bebawi
Hany Bebawi

18 September 2024 in Scientific Reports
Verified
Journal Article
Open access
PDF file
RKReem A. El Kalla
Reem A. El Kalla
NGNermine S. Ghoniem
Nermine S. Ghoniem
HZHala E. Zaazaa
Hala E. Zaazaa
AGAhmed Emad El Gendy
Ahmed Emad El Gendy
GSGhada A. Sedik
Ghada A. Sedik
A selective, precise, and accurate reversed HPLC method has been developed and validated for simultaneous separation and determination of two veterinary drugs, dipyrone and hyoscine, in their combined dosage form in the presence of their official impurities, namely 4-aminoantipyrine and tropic acid, in addition to the formulated preservative: phenol. The linearity range was found to be (1.00–35.00 µg/mL) for dipyrone and (2.50–50.00 µg/mL) for hyoscine. It exhibited a satisfactory linearity regression R (0.9999) for both drugs with LOD 0.22 µg/mL and 0.72 µg/mL and LOQ 0.65 µg/mL and 2.19 µg/mL for dipyrone and hyoscine, respectively. Additionally, the two cited drugs were also determined in the presence of dipyrone active metabolite 4-aminoantipyrine using diclofenac as an internal standard in bovine urine. The linearity range was found to be (15–75 µg/mL) for dipyrone, (2.5–60 µg/mL) for hyoscine, and (2.5–60 µg/mL) for 4-aminoantipyrine with linearity regression R (0.9999–0.9998). The LLOQ (15, 2.5, 2.5 µg/mL), LQC (45, 7.5, 7.5 µg/mL), MQC (55, 25, 25 µg/mL), and HQC (60, 50 50 µg/mL) were determined for dipyrone, hyoscine and 4-aminoantipyrine, respectively. UV detection was carried out at 220 nm. The method was validated according to the ICH guidelines, as well as according to FDA guidelines for determining both drugs in bioanalytical matrices and both proved accuracy and precision. A statistical comparison was made between the results obtained and those obtained by the reported method, showing no significant difference in accuracy and precision at p = 0.05. The suggested method was proved eco-friendly through a greenness assessment using two different tools (The analytical eco-scale scored 83, and the AGREE-Analytical Greenness Metric approach scored 0.83). The suggested method can be used in the routine work of quality control labs, screening for drug abuse, and ensuring clean sport for horse racing.